litlas
ログインアカウント作成

Maarten Boers

1987–2025 年に発表

189
論文数
54,018
被引用数
100
h 指数
186
i10 指数

被引用数

Maarten Boers の年別被引用数1961 年: 被引用 1 件1987 年: 被引用 1 件1990 年: 被引用 1 件1992 年: 被引用 1 件1994 年: 被引用 7 件1995 年: 被引用 21 件1996 年: 被引用 16 件1997 年: 被引用 21 件1998 年: 被引用 24 件1999 年: 被引用 66 件2000 年: 被引用 91 件2001 年: 被引用 89 件2002 年: 被引用 137 件2003 年: 被引用 229 件2004 年: 被引用 302 件2005 年: 被引用 311 件2006 年: 被引用 283 件2007 年: 被引用 290 件2008 年: 被引用 298 件2009 年: 被引用 336 件2010 年: 被引用 367 件2011 年: 被引用 395 件2012 年: 被引用 351 件2013 年: 被引用 407 件2014 年: 被引用 489 件2015 年: 被引用 584 件2016 年: 被引用 572 件2017 年: 被引用 657 件2018 年: 被引用 514 件2019 年: 被引用 1,623 件2020 年: 被引用 1,693 件2021 年: 被引用 1,679 件2022 年: 被引用 1,302 件2023 年: 被引用 825 件2024 年: 被引用 1,229 件2025 年: 被引用 460 件2026 年: 被引用 16 件1962〜1986 年は被引用が無いため表示していません1988〜1989 年は被引用が無いため表示していません1991 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,726 件、この内訳の 15.3%イギリス: 引用元論文 2,575 件、この内訳の 10.5%オランダ: 引用元論文 1,857 件、この内訳の 7.6%カナダ: 引用元論文 1,452 件、この内訳の 5.9%ドイツ: 引用元論文 1,227 件、この内訳の 5%オーストラリア: 引用元論文 1,171 件、この内訳の 4.8%イタリア: 引用元論文 1,042 件、この内訳の 4.3%中国: 引用元論文 980 件、この内訳の 4%フランス: 引用元論文 894 件、この内訳の 3.7%スペイン: 引用元論文 756 件、この内訳の 3.1%スイス: 引用元論文 572 件、この内訳の 2.3%デンマーク: 引用元論文 553 件、この内訳の 2.3%
0%15.3%その他 31.2%

機関

分野

  • Medicine77.5%
  • Health Professions3.8%
  • Biochemistry, Genetics and Molecular Biology3.4%
  • Decision Sciences2.7%
  • Social Sciences2.5%
  • Immunology and Microbiology2.4%
  • その他7.7%

トピック

  • Rheumatoid Arthritis Research and Therapies11.8%
  • Spondyloarthritis Studies and Treatments4.5%
  • Autoimmune and Inflammatory Disorders Research3.2%
  • Systemic Lupus Erythematosus Research3%
  • Osteoarthritis Treatment and Mechanisms2.8%
  • Musculoskeletal pain and rehabilitation2%
  • その他72.7%

共著者

全論文

検索で開く
  1. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

    著者: Beverley Shea, Jeremy Grimshaw, George A. Wells, Maarten Boers, Neil Andersson, Candyce Hamel, Ashley C Porter, Peter Tugwell, David Moher, L.M. Bouter - BMC Medical Research Methodology 2007 被引用: 4,413

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    著者: Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, J. Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Christopher D. Buckley, Frank Buttgereit, Vivian P. Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan J. Gómez‐Reino, Laure Gossec, J.-E. Gottenberg, Johanna M W Hazes, T. Huizinga, Meghna Jani, Д. Е. Каратеев, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 被引用: 5,775

  3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

    著者: Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B. McInnes, Alexandre Sepriano, Ronald van Vollenhoven, Maarten de Wit, Daniel Aletaha, Martin Aringer, Johan Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Myrna Cardiel, Diederik De Cock, Cătălin Codreanu, Maurizio Cutolo, Christopher J Edwards, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques‐Eric Gottenberg, Merete Lund Hetland, T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2020 被引用: 2,766

  4. COSMIN Risk of Bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a Delphi study

    著者: Lidwine B. Mokkink, Maarten Boers, Cees van der Vleuten, L.M. Bouter, Jordi Alonso, Donald L. Patrick, Henrica C. W. de Vet, Caroline B. Terwee - BMC Medical Research Methodology 2020 被引用: 549

  5. How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline

    著者: C.A.C. Prinsen, Sunita Vohra, Michael R. Rose, Maarten Boers, Peter Tugwell, Mike Clarke, Paula Williamson, Caroline B. Terwee - Trials 2016 被引用: 1,145

  6. The Delphi List

    著者: Arianne P. Verhagen, Henrica C. W. de Vet, Robert A. de Bie, Alphons G.H. Kessels, Maarten Boers, L.M. Bouter, Paul Knipschild - Journal of Clinical Epidemiology 1998 被引用: 2,382

  7. Measurement Properties of Visual Analogue Scale, Numeric Rating Scale, and Pain Severity Subscale of the Brief Pain Inventory in Patients With Low Back Pain: A Systematic Review

    著者: Alessandro Chiarotto, Lara Maxwell, Raymond Ostelo, Maarten Boers, Peter Tugwell, Caroline B. Terwee - Journal of Pain 2018 被引用: 678

  8. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews

    著者: Beverley Shea, Candyce Hamel, George A. Wells, L.M. Bouter, Elizabeth Kristjansson, Jeremy Grimshaw, David Henry, Maarten Boers - Journal of Clinical Epidemiology 2009 被引用: 1,770

  9. Recruitment and Retention of Older People in Clinical Research: A Systematic Literature Review

    著者: Noah D. Forsat, Andriko Palmowski, Yannick Palmowski, Maarten Boers, Frank Buttgereit - Journal of the American Geriatrics Society 2020 被引用: 212

  10. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    著者: David T. Felson, Josef S Smolen, George A. Wells, Bin Zhang, L. van Tuyl, Julia Funovits, Daniel Aletaha, Cornelia F Allaart, Joan M. Bathon, Stefano Bombardieri, Peter Brooks, Andrew Brown, Marco Matucci‐Cerinic, Hyon K. Choi, Bernard Combe, Maarten de Wit, Maxime Dougados, Paul Emery, Daniel E. Furst, Juan J. Gómez‐Reino, Gillian Hawker, Edward Keystone, Dinesh Khanna, John Kirwan, Tore K Kvien, Robert Landewé, Joachim Listing, Kaleb Michaud, E. Martín‐Mola, Pamela Montie, Theodore Pincus, Pamela Richards, Jeffrey N. Siegel, Lee S. Simon, Tuulikki Sokka, Vibeke Strand, Peter Tugwell, Alan Tyndall, Desirée van der Heijde, Suzanne Verstappen, Barbara White, Frederick Wolfe, A. Zink, Maarten Boers - Annals of the Rheumatic Diseases 2011 被引用: 1,019

  11. American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

    著者: David T. Felson, Jennifer J. Anderson, Maarten Boers, Claire Bombardier, Daniel E. Fürst, Charles H. Goldsmith, Linda M. Katz, Robert W. Lightfoot, Harold E. Paulus, Vibeke Strand, Peter Tugwell, Michael E. Weinblatt, H. James Williams, Frederick Wolfe, Stephanie Kieszak - Arthritis & Rheumatism 1995 被引用: 2,844

  12. Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

    著者: Maarten Boers, Linda Hartman, Daniela Opriș-Belinski, Reinhard Bos, Marc R. Kok, José António Pereira da Silva, Eduard N. Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G. Raterman, Zoltán Szekanecz, Frank Buttgereit, P. Masaryk, L Thomas Klausch, Sabrina Paolino, A. Schilder, Willem F. Lems, Maurizio Cutolo, LM Middelink, V Dekker, N van den Bulk, RMA Pinto, L Doerwald, S Manger, J Redol, K Prinsen, M Scholte-Voshaar, TLTA Jansen, C Codreanu, E Molenaar, JM van Laar, YPM Ruiterman, AERCH Boonen, AERCH Boonen, M Micaelo, J Costa, M Sieburg, JPL Spoorenberg, U Prothmann, MJ Saavedra, I Silva, MT Nurmohamed, JWG Jacobs, SW Tas, JWJ Bijlsma, R Christensen, YM Smulders, SH Ralston, DMFM van der Heijde, AF Marsman, WF Lems, C Rusthoven, M Bakkers, E Frazão Mateus, G Mendes, C Elling-Audersch, D Borucki, A Celano, P Corduta, O Constantinescu, P Richards, GJ Aanerud - Annals of the Rheumatic Diseases 2022 被引用: 161

  13. Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

    著者: Maarten Boers, John Kirwan, George A. Wells, Dorcas Beaton, Laure Gossec, Maria Antonietta D’Agostino, Philip G. Conaghan, Clifton O. Bingham, Peter Brooks, Robert Landewé, Lyn March, Lee S. Simon, Jasvinder A. Singh, Vibeke Strand, Peter Tugwell - Journal of Clinical Epidemiology 2014 被引用: 784

  14. Core outcome measurement instruments for clinical trials in nonspecific low back pain

    著者: Alessandro Chiarotto, Maarten Boers, Richard A. Deyo, Rachelle Buchbinder, Terry P. Corbin, Leonardo Oliveira Pena Costa, Nadine E. Foster, Margreth Grotle, Bart W. Koes, Francisco M. Kovacs, Chung‐Wei Christine Lin, Christopher G. Maher, Adam M. Pearson, Wilco C. Peul, Mark L. Schoene, Dennis C. Turk, Maurits W. van Tulder, Caroline B. Terwee, Raymond Ostelo - Pain 2017 被引用: 473

  15. Differences in descriptions of Kellgren and Lawrence grades of knee osteoarthritis

    著者: D. Schiphof, Maarten Boers, S.M. Bierma-Zeinstra - Annals of the Rheumatic Diseases 2008 被引用: 347

  16. Core outcome domains for clinical trials in non-specific low back pain

    著者: Alessandro Chiarotto, Richard A. Deyo, Caroline B. Terwee, Maarten Boers, Rachelle Buchbinder, Terry P. Corbin, Leonardo Oliveira Pena Costa, Nadine E. Foster, Margreth Grotle, Bart W. Koes, Francisco M. Kovacs, Chung‐Wei Christine Lin, Christopher G. Maher, Adam M. Pearson, Wilco C. Peul, Mark L. Schoene, Dennis C. Turk, Maurits W. van Tulder, Raymond Ostelo - European Spine Journal 2015 被引用: 393

  17. The HOME Core outcome set for clinical trials of atopic dermatitis

    著者: Hywel C Williams, Jochen Schmitt, Kim S Thomas, Phyllis I. Spuls, Eric L. Simpson, Christian Apfelbacher, Joanne R Chalmers, Masutaka Furue, Norito Katoh, Louise A. A. Gerbens, Yael A. Leshem, Laura Howells, Jasvinder A. Singh, Maarten Boers - Journal of Allergy and Clinical Immunology 2022 被引用: 151

  18. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials

    著者: David T. Felson, Jennifer J. Anderson, Maarten Boers, Claire Bombardier, Miriam Chernoff, Bruce J. Fried, Daniel E. Fürst, Charles H. Goldsmith, Stephanie Kieszak, Robert W. Lightfoot, Harold E. Paulus, Peter Tugwell, Michael E. Weinblatt, Rudolph Widmark, H. James Williams, Frederick Wolfe - Arthritis & Rheumatism 1993 被引用: 1,647

  19. The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis

    著者: Toby O. Smith, Gillian Hawker, David J. Hunter, Lyn March, Maarten Boers, Beverley Shea, Robin Christensen, Françis Guillemin, Caroline B. Terwee, Paula Williamson, Susanna Dodd, Ewa M. Roos, Richard F. Loeser, Thomas J. Schnitzer, M. Kloppenburg, Tuhina Neogi, C. Ladel, Gurdyal Kalsi, Ulrike Kaiser, Thomas Buttel, A. E. Ashford, Ali Mobasheri, Nigel Arden, Alan H. Tennant, Marc C. Hochberg, Maarten de Wit, Peter Tugwell, Philip G. Conaghan - The Journal of Rheumatology 2019 被引用: 190

  20. Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

    著者: Mickaël Hiligsmann, Cyrus Cooper, Nigel Arden, Maarten Boers, Jaime Branco, Maria Luisa Brandi, Olivier Bruyère, Françis Guillemin, Marc C. Hochberg, David J. Hunter, John А. Kanis, Tore K Kvien, Andrea Laslop, Jean‐Pierre Pelletier, Daniel Pinto, S Reiter-Niesert, René Rizzoli, Lucio C. Rovati, Johan L. Severens, Stuart L. Silverman, Y Tsouderos, Peter Tugwell, Jean‐Yves Reginster - Seminars in Arthritis and Rheumatism 2013 被引用: 320

  21. Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial

    著者: Wouter H Bos, Ben A. C. Dijkmans, Maarten Boers, R J van de Stadt, Dirkjan van Schaardenburg - Annals of the Rheumatic Diseases 2009 被引用: 173

  22. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

    著者: Cindy Strehl, J. W. J. Bijlsma, Maarten de Wit, Maarten Boers, N. Caeyers, Maurizio Cutolo, Bhaskar Dasgupta, William G Dixon, Rinie Geenen, T. Huizinga, Alison Kent, Annette de Thurah, Joachim Listing, Xavier Mariette, David Ray, Hans Ulrich Scherer, Raphaèle Séror, Cornelia M Spies, Simon Tarp, Dieter Wiek, Kevin Winthrop, Frank Buttgereit - Annals of the Rheumatic Diseases 2016 被引用: 331

  23. Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial

    著者: Laurette van Boheemen, Samina A. Turk, Marian H. van Beers-Tas, Wouter H Bos, Diane Marsman, E. N. Griep, Mirian Starmans‐Kool, Călin D. Popa, Alper van Sijl, Maarten Boers, Michael T. Nurmohamed, Dirkjan van Schaardenburg - RMD Open 2021 被引用: 72

  24. It's Good to Feel Better But It's Better To Feel Good and Even Better to Feel Good as Soon as Possible for as Long as Possible. Response Criteria and the Importance of Change at OMERACT 10: Figure 1.

    著者: Vibeke Strand, Maarten Boers, Leanne Idzerda, John Kirwan, Tore K Kvien, Peter Tugwell, Maxime Dougados - The Journal of Rheumatology 2011 被引用: 158